Follow-up after ED visits for opioid use disorder: Do they reduce future overdoses?

[1]  K. Zivin,et al.  Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018. , 2021, JAMA.

[2]  J. McMullan,et al.  Non-transport after Prehospital Naloxone Administration Is Associated with Higher Risk of Subsequent Non-fatal Overdose , 2021, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.

[3]  Erica A Abel,et al.  Validity of Incident Opioid Use Disorder (OUD) Diagnoses in Administrative Data: a Chart Verification Study , 2020, Journal of General Internal Medicine.

[4]  S. Wakeman,et al.  Beyond Buprenorphine: Models of Follow-up Care for Opioid Use Disorder in the Emergeny Department , 2020, The western journal of emergency medicine.

[5]  R. Purssell,et al.  Comparing mortality and healthcare utilization in the year following a paramedic-attended non-fatal overdose among people who were and were not transported to hospital: A prospective cohort study using linked administrative health data. , 2020, Drug and alcohol dependence.

[6]  S. Simpson,et al.  Prescribing Buprenorphine for Opioid Use Disorders in the ED: A Review of Best Practices, Barriers, and Future Directions , 2020, Open access emergency medicine : OAEM.

[7]  Peter J. Rock,et al.  Signal of increased opioid overdose during COVID-19 from emergency medical services data , 2020, Drug and Alcohol Dependence.

[8]  M. Olfson,et al.  Impact Of Long-Term Buprenorphine Treatment On Adverse Health Care Outcomes In Medicaid. , 2020, Health affairs.

[9]  P. Cunningham,et al.  Hospital Use Declines After Implementation Of Virginia Medicaid's Addiction And Recovery Treatment Services. , 2020, Health affairs.

[10]  M. Olfson,et al.  Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use Disorder. , 2019, The American journal of psychiatry.

[11]  T. Gomes,et al.  One-Year Mortality After Emergency Department Visit for Nonfatal Opioid Poisoning: A Population-Based Analysis. , 2019, Annals of emergency medicine.

[12]  Bonnie K. Lind,et al.  Inpatient Addiction Medicine Consultation and Post-Hospital Substance Use Disorder Treatment Engagement: a Propensity-Matched Analysis , 2019, Journal of General Internal Medicine.

[13]  Alex H. S. Harris,et al.  Predictive validity of a quality measure for intensive substance use disorder treatment , 2017, Substance abuse.

[14]  N. Rigotti,et al.  Inpatient Addiction Consultation for Hospitalized Patients Increases Post-Discharge Abstinence and Reduces Addiction Severity , 2017, Journal of General Internal Medicine.

[15]  N. Perrin,et al.  Assessing the accuracy of opioid overdose and poisoning codes in diagnostic information from electronic health records, claims data, and death records , 2017, Pharmacoepidemiology and drug safety.

[16]  G. D’Onofrio,et al.  Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention , 2017, Journal of General Internal Medicine.

[17]  T. Mark,et al.  Post-Discharge Treatment Engagement Among Patients with an Opioid-Use Disorder. , 2016, Journal of substance abuse treatment.

[18]  G. D’Onofrio,et al.  Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. , 2015, JAMA.

[19]  B. Anderson,et al.  Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial. , 2014, JAMA internal medicine.

[20]  George F Borm,et al.  The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method , 2014, BMC Medical Research Methodology.

[21]  D. Alford,et al.  A Transitional Opioid Program to Engage Hospitalized Drug Users , 2010, Journal of General Internal Medicine.